| Jena Weissenburger, ARNP | |
|
3737 Woodland Ave Ste 415, West Des Moines, IA 50266-1937 | |
| (515) 222-1999 | |
| Not Available |
| Full Name | Jena Weissenburger |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 3737 Woodland Ave Ste 415, West Des Moines, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063198760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | G174969 (Iowa) | Primary |
| Entity Name | Story County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023080504 PECOS PAC ID: 0547153884 Enrollment ID: O20040204000957 |
News Archive
Brainna McCormick was warming up for a high school basketball game last December when she noticed something wasn't right. An accomplished athlete, McCormick knows her body so when her heart started racing she knew something was wrong.
DUSA Pharmaceuticals, Inc. reported today that on the afternoon of August 5, 2010 the U.S. Food and Drug Administration notified DUSA that it has not granted Orphan Drug Designation for the use of Levulan (aminolevulinic acid HCl) Photodynamic Therapy for the prevention of cutaneous squamous cell carcinomas in patients who have a proven history of multiple localized cutaneous SCCs over a 12 month period.
Researchers at Johns Hopkins report that hospitalized patients do not receive more than one in 10 doses of doctor-ordered blood thinners prescribed to prevent potentially lethal or disabling blood clots, a decision they say may be fueled by misguided concern by patients and their caregivers.
Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.
› Verified 2 days ago
| Entity Name | Warren H Phillips Iii Phd Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427155647 PECOS PAC ID: 2860494085 Enrollment ID: O20070131000748 |
News Archive
Brainna McCormick was warming up for a high school basketball game last December when she noticed something wasn't right. An accomplished athlete, McCormick knows her body so when her heart started racing she knew something was wrong.
DUSA Pharmaceuticals, Inc. reported today that on the afternoon of August 5, 2010 the U.S. Food and Drug Administration notified DUSA that it has not granted Orphan Drug Designation for the use of Levulan (aminolevulinic acid HCl) Photodynamic Therapy for the prevention of cutaneous squamous cell carcinomas in patients who have a proven history of multiple localized cutaneous SCCs over a 12 month period.
Researchers at Johns Hopkins report that hospitalized patients do not receive more than one in 10 doses of doctor-ordered blood thinners prescribed to prevent potentially lethal or disabling blood clots, a decision they say may be fueled by misguided concern by patients and their caregivers.
Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.
› Verified 2 days ago
| Entity Name | Story County Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1215054713 PECOS PAC ID: 0547153884 Enrollment ID: O20090921000517 |
News Archive
Brainna McCormick was warming up for a high school basketball game last December when she noticed something wasn't right. An accomplished athlete, McCormick knows her body so when her heart started racing she knew something was wrong.
DUSA Pharmaceuticals, Inc. reported today that on the afternoon of August 5, 2010 the U.S. Food and Drug Administration notified DUSA that it has not granted Orphan Drug Designation for the use of Levulan (aminolevulinic acid HCl) Photodynamic Therapy for the prevention of cutaneous squamous cell carcinomas in patients who have a proven history of multiple localized cutaneous SCCs over a 12 month period.
Researchers at Johns Hopkins report that hospitalized patients do not receive more than one in 10 doses of doctor-ordered blood thinners prescribed to prevent potentially lethal or disabling blood clots, a decision they say may be fueled by misguided concern by patients and their caregivers.
Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jena Weissenburger, ARNP 3737 Woodland Ave Ste 415, West Des Moines, IA 50266-1937 Ph: (515) 222-1999 | Jena Weissenburger, ARNP 3737 Woodland Ave Ste 415, West Des Moines, IA 50266-1937 Ph: (515) 222-1999 |
News Archive
Brainna McCormick was warming up for a high school basketball game last December when she noticed something wasn't right. An accomplished athlete, McCormick knows her body so when her heart started racing she knew something was wrong.
DUSA Pharmaceuticals, Inc. reported today that on the afternoon of August 5, 2010 the U.S. Food and Drug Administration notified DUSA that it has not granted Orphan Drug Designation for the use of Levulan (aminolevulinic acid HCl) Photodynamic Therapy for the prevention of cutaneous squamous cell carcinomas in patients who have a proven history of multiple localized cutaneous SCCs over a 12 month period.
Researchers at Johns Hopkins report that hospitalized patients do not receive more than one in 10 doses of doctor-ordered blood thinners prescribed to prevent potentially lethal or disabling blood clots, a decision they say may be fueled by misguided concern by patients and their caregivers.
Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.
› Verified 2 days ago
Dr. Ryan Flug, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1089 Jordan Creek Pkwy Ste 200, West Des Moines, IA 50266 Phone: 515-531-8013 Fax: 833-983-2836 | |
Margaret Rosemary Lamparek, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave Ste 265, West Des Moines, IA 50266 Phone: 515-875-9450 Fax: 515-875-9457 | |
Pier Louise Osweiler, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5950 University Ave, Ste 280, West Des Moines, IA 50266 Phone: 515-875-9902 Fax: 515-875-9903 | |
Whitney Ann Johnston, ARNP, DNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5950 University Ave, Ste 151, West Des Moines, IA 50266 Phone: 515-875-9192 Fax: 515-875-9193 | |
Mrs. Paula Elizabeth Stageman, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6001 Westown Pkwy, West Des Moines, IA 50266 Phone: 515-224-1414 Fax: 515-224-5140 | |
Mrs. Kelsey Christensen, DNP, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave Ste 231, West Des Moines, IA 50266 Phone: 515-875-9090 Fax: 515-875-9312 | |
Molly Kathryn Elgin, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5880 University Ave Ste 103, West Des Moines, IA 50266 Phone: 515-633-3660 Fax: 515-362-4114 |